Eam Investors, LLC Invitae Corp Transaction History

Eam Investors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$33.06 - $56.93 $1.05 Million - $1.81 Million	-31,880 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$39.09 - $57.4 $295,950 - $434,575	-7,571 Reduced 19.19%	31,880 $1.33 Million
Q3 2020 Nov 13, 2020	SELL	$28.43 - $44.67 $830,980 - $1.31 Million	-29,229 Reduced 42.56%	39,451 $1.71 Million
Q2 2020 Aug 13, 2020	BUY	$11.71 - $30.29 $804,242 - $2.08 Million	68,680 New	68,680 $2.08 Million
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $2.73 Million - $4.13 Million	-157,354 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$10.65 - $25.75 $533,948 - $1.29 Million	50,136 Added 46.76%	157,354 $3.69 Million
Q4 2018 Feb 13, 2019	SELL	$9.26 - $16.38 $25,242 - $44,651	-2,726 Reduced 2.48%	107,218 $1.19 Million
Q3 2018 Nov 08, 2018	BUY	$7.54 - $18.31 $828,977 - $2.01 Million	109,944 New	109,944 $1.84 Million

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.